Real-world study tracks biosimilar zedora in early breast cancer
NCT ID NCT03892655
First seen Jan 11, 2026 · Last updated May 20, 2026 · Updated 14 times
Summary
This study looks at how well and how safely the biosimilar drug Zedora works in women with early-stage HER2+ breast cancer after surgery. About 170 women from several Brazilian hospitals will be followed to track cancer return, survival, and side effects. The goal is to gather real-world data on this treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Andrea Juliana Pereira de Santana Gomes
Natal, Rio Grande do Norte, 59075740, Brazil
-
Charles Alain Cordova Pinto
Lages, Santa Catarina, Brazil
-
Cláudio Rocha
Teresina, Piauí, 64049-200, Brazil
-
Cristina de Deus Anjos Tavares Sampaio
Campo Grande, Mato Grosso, Brazil
-
Daniel Fontes Santos de Teive e Argolo
Salvador, Estado de Bahia, 41810570, Brazil
-
Daniel Grabarz
Mogi das Cruzes, São Paulo, 08730500, Brazil
-
Kaique Almeida
São Paulo, São Paulo, Brazil
-
Karina Costa Maia Vianna
Curitiba, Paraná, Brazil
-
Luis Eduardo Rosa Zucca
Três Lagoas, Mato Grosso do Sul, Brazil
-
Mariana Scaranti
São Paulo, São Paulo, Brazil
-
Mateus Bongers Alessandretti
Porto Alegre, Rio Grande do Sul, Brazil
-
Micheline Campos Rezende
Muriaé, Minas Gerais, Brazil
-
Monique Celeste Tavares
São Paulo, São Paulo, 01509-900, Brazil
-
Márcia Cristina Colares Régis de Araújo
Fortaleza, Ceará, 60135285, Brazil
-
Rafaela Kirchner Piccoli
Ijuí, Rio Grande do Sul, Brazil
-
Raphael Luzorio Fernandes
Cachoeiro de Itapemirim, Espírito Santo, Brazil
-
Ruffo de Freitas Junior
Goiânia, Goiás, Brazil
-
Sabina Bandeira Aleixo
Cachoeiro de Itapemirim, Espírito Santo, Brazil
-
Sâmio Pimentel Ferreira
Belém, Pará, 66035265, Brazil
-
Sérgio Lunardon Padilha
Curitiba, Paraná, Brazil
-
Tomas Reinert
Caxias do Sul, Rio Grande do Sul, Brazil
-
William Hiromi Fuzita
Manaus, Amazonas, 69057205, Brazil
Conditions
Explore the condition pages connected to this study.